Search - tctmd.com

Displaying 361 - 380 of 391

Sort: Relevancy | Date

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

News Conference News TCT 2013

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

October 29, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in Germany?

Presenter: Bernhard Witzenbichler

October 28, 2013

Presentation TCT 2013

Bioresorbable Vascular Scaffolds

Presenter: Robert-Jan van Geuns

October 28, 2013

Presentation TCT 2013

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Presenter: Vladimir Dzavik

October 28, 2013

Presentation TCT 2013

Do I Really Need Bioresorbable Scaffolds in the United States?

Presenter: Gregg Stone

October 28, 2013

Presentation TCT 2013

Bioresorbable Scaffolds from Metal and Polymers: Landscape and Clinical Experiences

Presenter: Jochen W?hrle

October 28, 2013

News Industry News

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Status of the Self-Expanding and Balloon-Expandable Bioresorbable Scaffolds

Presenter: Michael Dake

October 27, 2013

Presentation TCT 2013

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

Presenter: Renu Virmani

October 27, 2013

News Daily News

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

Yael L. Maxwell

September 20, 2013

News Daily News

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

Yael L. Maxwell

September 20, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Industry News

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

May 01, 2013

News Daily News

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

March 25, 2013

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Conference News TCT 2012

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

October 24, 2012

Advertisement

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

State of the Stent: PCI Future Intact Despite Costs, Sociopolitical Factors

Do I Really Need Bioresorbable Scaffolds in Germany?

Bioresorbable Vascular Scaffolds

Bioresorbable Scaffolds in Bifurcation Applications: Technique Considerations and outcomes

Do I Really Need Bioresorbable Scaffolds in the United States?

Bioresorbable Scaffolds from Metal and Polymers: Landscape and Clinical Experiences

Arterial Remodeling Technologies (‘ART’) reports 30-day results for the ‘ARTDIVA’ clinical trial of its next-generation bioresorbable stent at ‘TCT 2013’ annual scientific meeting

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Status of the Self-Expanding and Balloon-Expandable Bioresorbable Scaffolds

Vascular Responses of Contemporary Durable Polymer DES, Bioabsorbable Polymer DES, Polymer-free DES and Fully Bioresorbable Scaffolds: Can Meaningful Differences in Vascular...

DESSOLVE I: SLS de Polímero Bioabsorbible, Prometedor en Lesiones De Novo

DESSOLVE I: Bioabsorbable Polymer SES Shows Promise in De Novo Lesions

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

BIOSOLVE-1 Shows Improvement in Paclitaxel-Eluting Bioabsorbable Stent

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Promising Outlook for Bioabsorbable Scaffolds, Polymers in Next-Generation Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content